Skip to content

Right POINT study

The use of Ventripoint to determine 3D right ventricular volume and function in children with a heart defect: validation in clinical practice. - Right POINT study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58435
Enrollment
109
Registered
2025-12-03
Start date
2025-10-27
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart condition for which echocardiography and VP were performed. Heart condition for which echocardiography and VP were performed.

Interventions

Ventripoint

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
No minimum to 17 Years

Inclusion criteria

Inclusion criteria: Patient DataChild (<18 years).Echocardiography and VP analysis performed at Erasmus MC.Healthcare ProfessionalsSonographer or pediatric cardiologist at Erasmus MC.

Exclusion criteria

Exclusion criteria: Patient DataUniventricular circulations.Heart transplantation.Cardiomyopathy.Echocardiogram technically not assessable.Healthcare ProfessionalsNone.

Design outcomes

Primary

MeasureTime frame
Are RV measurements obtained with VP and 2D echocardiography correlated with each other?What is the inter- and intra-observer variability of RV measurements obtained with VP?

Secondary

MeasureTime frame
Do RV measurements obtained with VP agree with CMR?Are RV measurements obtained with VP more strongly correlated with RV measurements from CMR than with those from 2D echocardiography?Are RV measurements obtained with VP more strongly correlated with exercise tolerance (peak VO2) than RV measurements from CMR or 2D echocardiography?What is the practical feasibility of VP?In what percentage of cases is VP successfully performed, and if not, why?How long does it take to perform VP acquisition and analysis?

Countries

Netherlands

Contacts

Public ContactB. Bartelds

Erasmus MC, Universitair Medisch Centrum Rotterdam

B.bartelds@erasmusmc.nl010-704 07 04

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026